<DOC>
	<DOCNO>NCT00649623</DOCNO>
	<brief_summary>The objective study investigate bioequivalence Mylan 's olmesartan medoxomil 40 mg tablet Sankyo 's Benicar® 40 mg tablet follow single , oral 40 mg ( 1 x 40 mg ) dose administer fasting condition .</brief_summary>
	<brief_title>Fasting Study Olmesartan Medoxomil Tablets 40 mg Benicar® Tablets 40 mg</brief_title>
	<detailed_description />
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<criteria>healthy , adult subject , 18 year older able swallow medication institutionalized subject history significant disease use prescription OTC medication within 14 day start study receive investigational product within 30 day prior start study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>